8ª Edição – Especial Simpósio

Advances in the diagnosis and use of targeted therapies were some of the highlights in the CNS during the 8th International Symposium on Oncoclinics

per: Grupo Oncoclínicas
Advances in the diagnosis and use of targeted therapies were some of the highlights in the CNS during the 8th International Symposium on Oncoclinics

Scientific commission

Bruno Ferrari
Bruno Ferrari
Carlos Gil
Carlos Gil
Paula Ugalde
Paula Ugalde
Sérgio Azevedo
Sérgio Azevedo

Contributors

Carolina Fittipaldi
Carolina Fittipaldi

The module on advances in the diagnosis and treatment of CNS tumors included the discussion of important topics, such as the role of pathology integrated with molecular and radiogenomic exams and the use of targeted therapies.

“One of the presentations at the symposium addressed the advances related to the diagnosis of brain tumors, which, since 2016, with the classification of the World Health Organization, started to integrate histological findings with molecular alterations present in primary tumors of the Central Nervous System”, says Carolina Fittipaldi Pessôa, oncologist at Oncoclínicas in Rio de Janeiro.

Another topic included was the correlation of magnetic resonance imaging (MRI) findings with molecular alterations present in gliomas, in which imaging tests play an important role in neuro-oncology decision making.

Access our website and read this article in its entirety, in addition to all the coverage of the 8th International Oncoclinical Symposium.

Access the full article of this study
Download
Share
Or share the link
Link copied to your desktop.L